SB 9200 treatment is associated with dose-dependent, transient increases of SDH but not of other liver enzymes.
figureposted on 23.08.2016, 17:30 by Kyle E. Korolowicz, Radhakrishnan P. Iyer, Stefanie Czerwinski, Manasa Suresh, Junming Yang, Seetharamaiyer Padmanabhan, Anjaneyulu Sheri, Rajendra K. Pandey, Jeffrey Skell, Judith K. Marquis, Bhaskar V. Kallakury, Robin D. Tucker, Stephan Menne
Changes in mean serum levels of SDH, AST and ALT in response to SB 9200 treatment at a low (A) or high dose (B). Changes in mean serum WHV DNA relative to T0 is plotted on the left y-axis. Error bars represent the standard error of the mean.